Barclays Upgrades Keurig Dr Pepper to 'Buy', Sets $36 Target

Barclays analyst Lauren Lieberman issued a 'buy' rating for Keurig Dr Pepper, raising the price target to $36, a 7.78% upside from the current price.

Key Points

  • Barclays raised its rating on Keurig Dr Pepper to 'buy' with a $36 target on June 25, 2026.
  • Barclays's $36 price target implies 7.78% upside from Keurig Dr Pepper Inc.'s ($KDP) current $33.40 share price.
  • Shares of NasdaqGS:KDP traded near $31.40 on Thursday, with a market cap of $42 billion and a P/E ratio of 22.87.
  • Recent insider activity includes sales by CEO Timothy Cofer and Senior VP Angela Stephens, while FMR LLC and BlackRock increased their holdings.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

On June 25, 2026, Barclays analyst Lauren Lieberman upgraded Keurig Dr Pepper Inc. (NasdaqGS:KDP) to a 'buy' rating, setting a new price target of $36. This change comes as Keurig Dr Pepper's shares traded near $31.40 on Thursday.

Analyst rating track record

Barclays vs. the S&P 500

YTD return +19.57% hypothetical
All-time return +36.34% S&P 500 +39.26%
vs. S&P 500 -2.92% behind the index

Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.

Keurig Dr Pepper Inc. Stock Up 3.8%

Shares of Keurig Dr Pepper traded around $31.40 on Thursday. The company, with a market cap of about $42 billion, has a P/E ratio of 22.87 and a forward P/E of 12.23. Its stock has experienced a 52-week low of $24.88 and a high of $35.94, while maintaining a 50-day moving average of $29.05 and a 200-day moving average of $27.95. The company's beta is 0.424, indicating lower volatility compared to the market.

12-month forecast

$KDP price target

Past daily closes and this analyst's 12-month price target. Not investment advice.

Insider Buying and Selling at Keurig Dr Pepper Inc.

Recent insider activity at Keurig Dr Pepper includes several transactions by CEO Timothy Cofer and Senior VP & Controller Angela Stephens. On May 20, 2026, Timothy Cofer sold 34,670 shares at an average price of $28.69. Angela Stephens executed multiple transactions on June 1, 2026, buying and selling shares, with a notable sale of 1,161 shares at $30.20.

Analysts Set New Price Targets

On June 25, 2026, Barclays upgraded its rating of Keurig Dr Pepper to 'buy' and set a price target of $36. Earlier, on June 12, 2026, Bernstein initiated coverage on the company with a 'buy' rating and a $38 target. The consensus recommendation for Keurig Dr Pepper is 'buy', with an average target price of $33.53 based on 17 analyst opinions.

About Keurig Dr Pepper

Keurig Dr Pepper Inc. is a major beverage company headquartered in Frisco, Texas. It owns, manufactures, and distributes a wide range of beverages and single-serve brewing systems across the United States and internationally. The company operates through segments focused on refreshment beverages, coffee, and international markets. Its product lineup includes popular brands like Dr Pepper, Canada Dry, Snapple, and Green Mountain Coffee Roasters. Led by CEO Timothy P. Cofer, Keurig Dr Pepper employs approximately 30,600 people.

Bottom Line

Barclays' upgrade to a 'buy' rating with a $36 target reflects increased confidence in Keurig Dr Pepper. Investors often track such upgrades as they can signal potential future performance. Keep in mind, analyst ratings and targets are based on current assessments and could change. Always consider these insights as part of a broader investment strategy.

Get Keurig Dr Pepper Inc. alerts

New 13F filings, insider trades, and analyst moves on $KDP, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.